TrialStem cell research & therapy2024

Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial.

Violaine K Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.